logo
Select company
Select metric
-100.22%Return on Equity
VS
Market
11
Sector
30
Industry
38
History
67
$ 1.11Close
$ 0.77 - $ 1.54 52-Week Range
Ticker Information

Ticker

RNXT

Company Name

RENOVORX INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RENOVORX INC - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RNXT - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
6/30/2025$ 10.64M$ -10.66M-100.22%
3/31/2025$ 13.16M$ -10.16M-77.21%
12/31/2024$ 4.48M$ -8.81M-196.83%
9/30/2024$ 7.07M$ -9.16M-129.59%
6/30/2024$ 9.27M$ -8.11M-87.5%
3/31/2024$ 1.77M$ -8.05M-455.63%
12/31/2023$ -3M$ -10.23M0%
9/30/2023$ 6K$ -9.16M-152683.33%
6/30/2023$ 1.19M$ -9.88M-831.31%
3/31/2023$ 3.26M$ -10.14M-311.52%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RENOVORX INC's latest trailing twelve months (TTM) ROE stands at 0%.
  • Over the past 5 years, RENOVORX INC's average ROE has been -11945.55%.
  • The median ROE for RENOVORX INC during this period was -129.59%
  • RENOVORX INC reached its highest ROE over the past 5 years at -41.2%.
  • The lowest ROE recorded by RENOVORX INC in the same timeframe -152683.33%

RENOVORX INC's ROE vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

ROE Benchmarks
CompanyROE
ADVM : ADVERUM BIOTECHNOLOGIES INC -RLYB : RALLYBIO CORP -90.62%ICU : SEASTAR MEDICAL HOLDING CORP -439.12%LEXX : LEXARIA BIOSCIENCE CORP -205.16%CLNN : CLENE INC -COEP : COEPTIS THERAPEUTICS HOLDINGS INC -170.1%BRTX : BIORESTORATIVE THERAPIES INC -221.32%VTGN : VISTAGEN THERAPEUTICS INC -98.26%LYRA : LYRA THERAPEUTICS INC -2394.33%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC -

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for RENOVORX INC is calculated as follows: Net Inc. Cmn. [ $ -3.8M ] / Equity [ $ -14.66M ]
(=) ROE [ 0% ]

RNXT - Return on Equity, Last 5 years

-152683.33%

Minimum

Sep 30, 2023

-41.2%

Maximum

Dec 31, 2021

-11945.55%

Average

-129.59%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%